This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Master Pharm Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Belangrijke informatie
16.1%
Verhouding schuld/eigen vermogen
zł13.30m
Schuld
Rente dekkingsratio | 40.5x |
Contant | zł13.57m |
Aandelen | zł82.62m |
Totaal verplichtingen | zł32.11m |
Totaal activa | zł114.73m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27Analyse van de financiële positie
Kortlopende schulden: MPH's short term assets (PLN60.0M) exceed its short term liabilities (PLN20.4M).
Langlopende schulden: MPH's short term assets (PLN60.0M) exceed its long term liabilities (PLN11.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: MPH has more cash than its total debt.
Schuld verminderen: MPH's debt to equity ratio has increased from 0% to 16.1% over the past 5 years.
Schuldendekking: MPH's debt is well covered by operating cash flow (124.6%).
Rentedekking: MPH's interest payments on its debt are well covered by EBIT (40.5x coverage).